| # | Title | Journal | Year | Citations |
|---|
| 1 | Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review | Infectious Diseases of Poverty | 2020 | 1,518 |
| 2 | Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues | Infectious Diseases of Poverty | 2020 | 1,195 |
| 3 | A mathematical model for simulating the phase-based transmissibility of a novel coronavirus | Infectious Diseases of Poverty | 2020 | 622 |
| 4 | Yaws in the Philippines: first reported cases since the 1970s | Infectious Diseases of Poverty | 2020 | 370 |
| 5 | Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis | Infectious Diseases of Poverty | 2021 | 244 |
| 6 | Global burden, distribution, and interventions for infectious diseases of poverty | Infectious Diseases of Poverty | 2014 | 225 |
| 7 | Psychological status and behavior changes of the public during the COVID-19 epidemic in China | Infectious Diseases of Poverty | 2020 | 174 |
| 8 | Malaria: Global progress 2000 – 2015 and future challenges | Infectious Diseases of Poverty | 2016 | 160 |
| 9 | Neglected tropical diseases: an effective global response to local poverty-related disease priorities | Infectious Diseases of Poverty | 2020 | 158 |
| 10 | Psychological impact of COVID-19 on medical care workers in China | Infectious Diseases of Poverty | 2020 | 154 |
| 11 | Assessing preventive health behaviors from COVID-19: a cross sectional study with health belief model in Golestan Province, Northern of Iran | Infectious Diseases of Poverty | 2020 | 152 |
| 12 | Controlling schistosomiasis with praziquantel: How much longer without a viable alternative? | Infectious Diseases of Poverty | 2017 | 143 |
| 13 | Current challenges in treatment options for visceral leishmaniasis in India: a public health perspective | Infectious Diseases of Poverty | 2016 | 137 |
| 14 | The global epidemiology of clonorchiasis and its relation with cholangiocarcinoma | Infectious Diseases of Poverty | 2012 | 136 |
| 15 | Toxocariasis: a silent threat with a progressive public health impact | Infectious Diseases of Poverty | 2018 | 134 |
| 16 | Malaria epidemiology and interventions in Ethiopia from 2001 to 2016 | Infectious Diseases of Poverty | 2018 | 131 |
| 17 | The cross-cutting contribution of the end of neglected tropical diseases to the sustainable development goals | Infectious Diseases of Poverty | 2017 | 130 |
| 18 | Elimination of tropical disease through surveillance and response | Infectious Diseases of Poverty | 2013 | 129 |
| 19 | Current status and perspectives of Clonorchis sinensis and clonorchiasis: epidemiology, pathogenesis, omics, prevention and control | Infectious Diseases of Poverty | 2016 | 125 |
| 20 | Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis Control: epidemiological evaluation results | Infectious Diseases of Poverty | 2016 | 125 |
| 21 | Assessing Ebola-related web search behaviour: insights and implications from an analytical study of Google Trends-based query volumes | Infectious Diseases of Poverty | 2015 | 124 |
| 22 | Moving from control to elimination of schistosomiasis in sub-Saharan Africa: time to change and adapt strategies | Infectious Diseases of Poverty | 2017 | 123 |
| 23 | Fighting against the common enemy of COVID-19: a practice of building a community with a shared future for mankind | Infectious Diseases of Poverty | 2020 | 122 |
| 24 | Epidemiological characteristics of human prion diseases | Infectious Diseases of Poverty | 2016 | 117 |
| 25 | Need of surveillance response systems to combat Ebola outbreaks and other emerging infectious diseases in African countries | Infectious Diseases of Poverty | 2014 | 113 |
| 26 | African swine fever: an unprecedented disaster and challenge to China | Infectious Diseases of Poverty | 2018 | 109 |
| 27 | Safety of SARS-CoV-2 vaccines: a systematic review and meta-analysis of randomized controlled trials | Infectious Diseases of Poverty | 2021 | 109 |
| 28 | “Candidatus anaplasma camelii” in one-humped camels (Camelus dromedarius) in Morocco: a novel and emerging Anaplasma species? | Infectious Diseases of Poverty | 2017 | 106 |
| 29 | Schistosomiasis is more prevalent than previously thought: what does it mean for public health goals, policies, strategies, guidelines and intervention programs? | Infectious Diseases of Poverty | 2017 | 106 |
| 30 | The burden of mental health in lymphatic filariasis | Infectious Diseases of Poverty | 2015 | 102 |
| 31 | Chinese social media reaction to the MERS-CoV and avian influenza A(H7N9) outbreaks | Infectious Diseases of Poverty | 2013 | 97 |
| 32 | Schistosomiasis control and the health system in P.R. China | Infectious Diseases of Poverty | 2012 | 95 |
| 33 | Assessment of morbidity due to Schistosoma japonicum infection in China | Infectious Diseases of Poverty | 2014 | 95 |
| 34 | Abnormal immunity of non-survivors with COVID-19: predictors for mortality | Infectious Diseases of Poverty | 2020 | 94 |
| 35 | Are malaria elimination efforts on right track? An analysis of gains achieved and challenges ahead | Infectious Diseases of Poverty | 2019 | 92 |
| 36 | Surveillance-response systems: the key to elimination of tropical diseases | Infectious Diseases of Poverty | 2014 | 91 |
| 37 | Impact of past and on-going changes on climate and weather on vector-borne diseases transmission: a look at the evidence | Infectious Diseases of Poverty | 2019 | 91 |
| 38 | Impact of co-infections with enteric pathogens on children suffering from acute diarrhea in southwest China | Infectious Diseases of Poverty | 2016 | 89 |
| 39 | Control of malaria and other vector-borne protozoan diseases in the tropics: enduring challenges despite considerable progress and achievements | Infectious Diseases of Poverty | 2014 | 88 |
| 40 | Innovation in neglected tropical disease drug discovery and development | Infectious Diseases of Poverty | 2018 | 88 |
| 41 | Seroprevalence of dengue among healthy adults in a rural community in Southern Malaysia: a pilot study | Infectious Diseases of Poverty | 2018 | 87 |
| 42 | Levels of insecticide resistance to deltamethrin, malathion, and temephos, and associated mechanisms in Aedes aegypti mosquitoes from the Guadeloupe and Saint Martin islands (French West Indies) | Infectious Diseases of Poverty | 2017 | 86 |
| 43 | Catastrophic total costs in tuberculosis-affected households and their determinants since Indonesia’s implementation of universal health coverage | Infectious Diseases of Poverty | 2018 | 80 |
| 44 | Characterizing a large outbreak of dengue fever in Guangdong Province, China | Infectious Diseases of Poverty | 2016 | 79 |
| 45 | Snail-borne parasitic diseases: an update on global epidemiological distribution, transmission interruption and control methods | Infectious Diseases of Poverty | 2018 | 79 |
| 46 | Estimation of exponential growth rate and basic reproduction number of the coronavirus disease 2019 (COVID-19) in Africa | Infectious Diseases of Poverty | 2020 | 79 |
| 47 | Implementing a “free” tuberculosis (TB) care policy under the integrated model in Jiangsu, China: practices and costs in the real world | Infectious Diseases of Poverty | 2016 | 78 |
| 48 | Elimination of schistosomiasis: the tools required | Infectious Diseases of Poverty | 2017 | 77 |
| 49 | COVID-19 vaccination intention and vaccine characteristics influencing vaccination acceptance: a global survey of 17 countries | Infectious Diseases of Poverty | 2021 | 77 |
| 50 | Containment of COVID-19 in Ethiopia and implications for tuberculosis care and research | Infectious Diseases of Poverty | 2020 | 76 |
